BIOCOPY

Biocopy is breaking new ground in finding cures for cancer with an AI-driven platform... BioCopy was founded in 2019. Our technology was quickly recognized as leading-edge in early drug discovery, drug candidate safety and efficacy assessments. When we joined forces with Perspix BioTech and their automated laboratory in early 2024, we took drug discovery and development to a completely new level... This is where BioCopy comes into play. We are the world's first research-based biotechnology company with an artificial intelligence (AI)-driven, end-to-end automated, proprietary platform. We discover and develop highly powerful yet safe drug candidates for future biotherapeutics at an unprecedented speed, quality, and quantity. They identify cancer cells more accurately than ever before, making them safer and more efficient than conventionally-developed drugs. This unleashes the immune system's power on a scale that has never been seen before.

Also known as: BioCopy AG

Registration numbers: CHE-363.379.669 (W)

Primary location: Basel Belgium